Scarica l'app Stockscreener
142.69
1.39%
1.96
Glaukos Corporation Borsa (GKOS) Ultime notizie
Ophthalmic Devices Market Worth 66.71 Bn by 2027 | Hoya Group, Gulden Ophthalmics, FCI Ophthalmics, Glaukos - EIN News
Analyst Scoreboard: 5 Ratings For Glaukos - Inkl
Glaukos price target raised to $149 from $140 at BTIG - TipRanks
Glaukos Stock Soars 77.9% Year to Date: What's Behind the Rally? - MSN
Loomis Sayles & Co. L P Grows Position in Glaukos Co. (NYSE:GKOS) - MarketBeat
Intech Investment Management LLC Purchases 9,088 Shares of Glaukos Co. (NYSE:GKOS) - MarketBeat
Eagle Asset Management Inc. Has $11.12 Million Stake in Glaukos Co. (NYSE:GKOS) - MarketBeat
6,080 Shares in Glaukos Co. (NYSE:GKOS) Bought by Jennison Associates LLC - MarketBeat
Glaukos (NYSE:GKOS) Reaches New 1-Year HighWhat's Next? - MarketBeat
Glaukos stock soars to all-time high of $145.97 amid robust growth - Investing.com Australia
When (GKOS) Moves Investors should Listen - Stock Traders Daily
Connor Clark & Lunn Investment Management Ltd. Has $6.11 Million Holdings in Glaukos Co. (NYSE:GKOS) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Buys New Shares in Glaukos Co. (NYSE:GKOS) - MarketBeat
Glaukos stock soars to all-time high of $145.97 amid robust growth By Investing.com - Investing.com South Africa
Primecap Management Co. CA Increases Stock Position in Glaukos Co. (NYSE:GKOS) - MarketBeat
Segall Bryant & Hamill LLC Sells 4,327 Shares of Glaukos Co. (NYSE:GKOS) - MarketBeat
Glaukos Co. (NYSE:GKOS) is Brown Capital Management LLC's 4th Largest Position - MarketBeat
Glaukos (FRA:6GJ) Cyclically Adjusted FCF per Share : €-0.43 (As of Sep. 2024) - GuruFocus.com
Glaukos Co. (NYSE:GKOS) Shares Bought by Victory Capital Management Inc. - MarketBeat
Glaukos Corp (GKOS) Trading 4.94% Higher on Nov 19 - GuruFocus.com
First Turn Management LLC Takes Position in Glaukos Co. (NYSE:GKOS) - MarketBeat
LMR Partners LLP Grows Holdings in Glaukos Co. (NYSE:GKOS) - MarketBeat
Oppenheimer Asset Management Inc. Sells 3,974 Shares of Glaukos Co. (NYSE:GKOS) - MarketBeat
Here's Why You Should Retain Glaukos (GKOS) Stock for Now - MSN
Glaukos Revolutionizes Glaucoma Treatment with iDose TR Approval - TipRanks
Brown Capital Management LLC's Strategic Reduction in Glaukos Co - GuruFocus.com
(GKOS) Long Term Investment Analysis - Stock Traders Daily
Glaukos Co. (NYSE:GKOS) Shares Bought by WCM Investment Management LLC - MarketBeat
Principal Financial Group Inc. Sells 9,441 Shares of Glaukos Co. (NYSE:GKOS) - MarketBeat
Lisanti Capital Growth LLC Sells 20,320 Shares of Glaukos Co. (NYSE:GKOS) - MarketBeat
GKOS Stock Declines Despite Q3 Earnings & Revenues Beat Estimates - MSN
Glaukos Announces Participation in Upcoming Investor Conferences - BioSpace
William Blair Comments on Glaukos' Q4 Earnings (NYSE:GKOS) - MarketBeat
Glaukos to Present at 5 Major Healthcare Investor Conferences in Q4 2024 | GKOS Stock News - StockTitan
Glaukos Corporation (NYSE:GKOS) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance
Glaukos stock soars to all-time high of $139.53 amid robust growth - Investing.com
Glaukos Corporation (NYSE:GKOS) Q3 2024 Earnings Call Transcript - MSN
Glaukos price target raised to $145 from $135 at Wells Fargo - Yahoo Finance
Glaukos Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Glaukos price target raised to $140 from $139 at BTIG - TipRanks
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market | Futu - WICZ
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now - MSN
Glaukos (NYSE:GKOS) Shares Gap DownHere's What Happened - MarketBeat
Glaukos (NYSE:GKOS) Releases Earnings Results, Beats Estimates By $0.20 EPS - MarketBeat
Earnings call: Glaukos reports strong Q3 growth, raises 2024 guidance - Investing.com
Glaukos (GKOS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
JPMorgan Chase & Co. Issues Positive Forecast for Glaukos (NYSE:GKOS) Stock Price - MarketBeat
Piper Sandler reaffirms stock target on Glaukos post-Q3 beat - Investing.com
BTIG reiterates Buy on Glaukos stock as strong iDose sales support growth outlook - Investing.com
Glaukos Co. (NYSE:GKOS) Receives $130.45 Average PT from Analysts - MarketBeat
Glaukos Corp (GKOS) Q3 2024 Earnings Call Highlights: Record Sal - GuruFocus.com
Glaukos Corp (GKOS) Q3 2024 Earnings Call Highlights: Record Sales and Raised Guidance Amid ... - Yahoo Finance
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):